These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 15302796)

  • 1. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
    Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
    Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
    Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.
    Antzelevitch C; Belardinelli L; Wu L; Fraser H; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Goodrow RJ; Scornik F; Perez G
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S65-83. PubMed ID: 15378132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
    Schram G; Zhang L; Derakhchan K; Ehrlich JR; Belardinelli L; Nattel S
    Br J Pharmacol; 2004 Aug; 142(8):1300-8. PubMed ID: 15277312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
    Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
    J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
    Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
    Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
    Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
    Circulation; 2007 Sep; 116(13):1449-57. PubMed ID: 17785620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
    Song Y; Shryock JC; Wu L; Belardinelli L
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
    Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
    Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.
    Wu L; Shryock JC; Song Y; Li Y; Antzelevitch C; Belardinelli L
    J Pharmacol Exp Ther; 2004 Aug; 310(2):599-605. PubMed ID: 15031300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
    Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
    Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular basis for complex T waves and arrhythmic activity following combined I(Kr) and I(Ks) block.
    Emori T; Antzelevitch C
    J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1369-78. PubMed ID: 11797994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes.
    Guo D; Liu Q; Liu T; Elliott G; Gingras M; Kowey PR; Yan GX
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):79-85. PubMed ID: 20980921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
    Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
    Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential.
    Gao Z; Milnes JT; Choisy SC; Leach MJ; Hancox JC; James AF
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1088-96. PubMed ID: 16445575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
    Wu L; Rajamani S; Li H; January CT; Shryock JC; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1048-57. PubMed ID: 19592609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
    Undrovinas AI; Belardinelli L; Undrovinas NA; Sabbah HN
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1(Suppl 1):S169-S177. PubMed ID: 16686675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.